Knowledge Centre · Marketing authorisation

Procedural rejection of an MA application: why the 30-day response period still matters

Melvin International Consulting3 min read

In an announcement published on 13 October 2026, TİTCK opened a new route for marketing authorisation (MA) applications that have been rejected on procedural grounds. Provided certain conditions are met, the process can continue from the stage it had reached before the rejection. This does not diminish the importance of the 30-day response period, the most common cause of procedural rejection. If anything, it makes the cost of missing the deadline more visible.

When is an application rejected on procedural grounds?

Under Article 13 of the Regulation on the Marketing Authorisation of Human Medicinal Products, an application is rejected on procedural grounds and cancelled in four cases:

  • The second application is not submitted on time with the deficiencies found in the first preliminary assessment remedied, or the second application does not remedy them
  • The MA fee is not paid within 60 days of the official notification that the authorisation process has been completed
  • Outside the preliminary assessment, the information and documents requested by TİTCK, or a statement explaining why they cannot be provided together with the date by which they will be submitted, are not provided within 30 days at the latest
  • The documents are not submitted when the date given in that statement arrives

What does the 30-day period cover?

Requests for information and documents issued by TİTCK during the assessment must be answered within 30 days. The answer can take one of two forms: the requested documents, or a statement explaining why they cannot be provided and the date by which they will be submitted. The Regulation requires that the date given does not exceed three years and that the documents to be submitted meet current scientific requirements. TİTCK may make an exception for conditional MA applications. If a request is left unanswered for 30 days, the application is rejected on procedural grounds, regardless of the technical assessment of the dossier.

What did the 13 October 2026 announcement change?

The announcement is based on a Ministerial Approval dated 1 October 2026. In all procedural rejections other than those at the preliminary assessment stage:

  • The dossier is not returned with the notice of procedural rejection.
  • Within six months of notification of the rejection, the applicant may request that the authorisation process be continued. This requires payment of the MA application fee and any other applicable fees in the TİTCK fee schedule.
  • The process then continues from the stage it had reached before the procedural rejection.
  • TİTCK may ask the applicant for additional information, documents or updates.

Previously, the only option for such products was to submit a new MA application under the conditions set out in Article 13 of the Regulation.

Why does the 30-day period still matter?

  • Cost: A continuation request means paying the MA application fee again.
  • A second deadline: If the six-month window is missed, this route closes as well.
  • Further requests: As TİTCK may ask for additional documents or updates, the dossier does not stay as it was at the time of rejection.
  • Lost time: The dossier does not move forward between the rejection and the continuation request.
  • Rejections outside the scope: Rejections at the preliminary assessment stage cannot use this route.

In short, the new arrangement is a safety net, but it is no substitute for submitting the documents, or a dated statement, within 30 days.

Sources: Regulation on the Marketing Authorisation of Human Medicinal Products (Official Gazette 11.12.2021/31686, current text), Article 13; TİTCK Department of Drug Licensing announcement RD/2026/10/1 (13.10.2026); TİTCK announcement RD/2021/12/2 (11.12.2021). This article is for general information; current legislation and TİTCK announcements prevail.